Enokizumab - CISMeF

Preferred Label : Enokizumab;

NCIt synonyms : Anti-IL9 Monoclonal Antibody MEDI-528;

NCIt definition : A humanized monoclonal antibody directed against the cytokine interleukin-9 (IL-9), with potential immunomodulating activity. Upon administration, enokizumab binds to and blocks the activity of IL-9, thereby preventing IL-9-mediated effects. IL-9, a T-helper cell type 2-derived cytokine, is involved in airway inflammation and hyperrreactivity.;

UNII : I4BE5F78HR;

CAS number : 909875-08-7;

Molecule name : 7F3com-2H2; MEDI 528;

Details

Origin ID

C97929;

UMLS CUI

C3273705;

Automatic exact mappings (from CISMeF team)
- enokizumab [MeSH concept]
Currated CISMeF NLP mapping
- enokizumab [MeSH Supplementary Concept]
See also inter- (CISMeF)
- IL9 protein, human [MeSH Supplementary Concept]
- Interleukin-9 [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- enokizumab [MeSH Supplementary Concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients